Feature|Videos|April 1, 2025
Addressing Sources, Reformulations, and Upcoming Regulatory Deadlines
The experts explore the sources of nitrosamines in drug products, considerations for reformulations and risk assessments, and the approaching regulatory deadlines.
Advertisement
Episodes in this series
Advertisement
Advertisement
Advertisement
Trending on LCGC International
1
Sample Preparation Strategies for PFAS Analysis
2
HTC-19 Insights: Why develop HPLC—XRF?
3
The PFAS Analyst’s Wish List
4
AI/ML in Practice: Machine-learning Prediction of Chromatographic Retention Times for Small Molecules in Pharmaceutical Applications
5